Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

["Medication, Administered": "Opioid Antagonist"]

Performance/Reporting Period
2025
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for the opioid antagonist medications naloxone and nalmefine administered to reverse over-administration of opioids in the hospital setting
Data Element Scope: This value set may use a model element related to Medication
Inclusion Criteria: Includes concepts that represent non-enteral (intranasal, intramuscular, intravenous, subcutaneous, inhalation) forms of naloxone and nalmefene medications
Exclusion Criteria: Excludes all other types of opioid antagonists such as naltrexone. Excludes combination medications that contain both an opioid antagonist and an opioid. Excludes concepts that represent enteral (e.g., oral, gastrointestinal) forms of naloxone and nalmefene medications.

Constrained to codes in the Opioid Antagonist value set (2.16.840.1.113762.1.4.1248.119)

QDM Datatype and Definition

"Medication, Administered"

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.

Timing:

  • relevant dateTime references the time the medication is administered if it was given or taken at a single point in time.
  • relevantPeriod references a start and stop time for medication administration if the administration event occurred over a time interval (e.g., an intravenous infusion). The relevantPeriod addresses:
    • startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion).
    • stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion).
  • author dateTime references the time the action was recorded.
  • Refer to the eCQM expression to determine allowable timings to meet measure criterion.

Notes:

  • Measure developers should address multiple administrations over a period of time using CQL logic.
  • negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.

Refer to Special Cases in Section 5.7 for scenarios to consider in calculating cumulative medication duration.

QDM Attributes

relevantDateTime

relevant dateTime addresses the time an activity occurs as a single point in time. If the activity occurs over a period of time, use relevantPeriod.

relevantPeriod

relevantPeriod addresses the time between the start of an action to the end of an action. Each QDM datatype using relevantPeriod defines specific definitions for the start and stop time for the action listed.

Note: negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod

route

Refers to the path by which the medication or substance should be taken into the body system, such as intradermally, intrathecally, intramuscularly, intranasally, intravenously, orally, rectally, subcutaneously, sublingually, topically, or vaginally.
Last Updated: Jun 26, 2024